The Delaware R&D Tax Credit: A Deep Dive into the 50% Apportionment Rate (Method B)

The 50% Apportionment Rate (General Rule ASC) is one of two elective methods for calculating the Delaware R&D tax credit, applicable to standard (non-small) businesses. It calculates the credit as half (50%) of the portion of the federal Alternative Simplified Credit (ASC) that is physically sourced to Delaware, based on a ratio of local to total Qualified Research Expenses (QREs).

I. Executive Summary: The Delaware R&D Credit, Method B (ASC General Rule)

The Delaware Research and Development (R&D) Tax Credit is a powerful state incentive governed by 30 Del. C. § 2070, offering businesses a fully refundable credit for qualified research expenses incurred within the state.1 For standard taxpayers—those exceeding $20 million in average annual gross receipts—this credit provides an annual choice between two distinct calculation methodologies.

Method B, formally designated as the General Rule under the Alternative Simplified Credit (ASC) methodology, defines the resulting credit as 50% of Delaware’s apportioned share of the taxpayer’s federal R&D tax credit calculated using IRC § 41(c)(5).3 This method is a critical mechanism, particularly for multi-state corporations, as it allows the state incentive to be derived directly from the federal credit calculation, adjusted only by the physical location of the research activity. Since the credit is fully refundable—meaning any excess over the state tax liability is returned to the taxpayer in cash—optimizing the calculation via Method B often translates directly into enhanced liquidity and immediate cash flow benefits, making this decision a central component of annual tax planning.

A. The Strategic Significance of Method B

The policy decision by Delaware to make its R&D credit fully refundable elevates the importance of electing the optimal calculation path. While many state R&D credits only serve to offset state tax liability, the provision for unused Delaware credits to be paid as cash establishes a higher realized economic benefit compared to non-refundable credits that must be carried forward.1

Method B, leveraging the federal ASC, often offers a more predictable and potentially higher credit amount than the traditional incremental approach (Method A), especially for businesses with highly fluctuating R&D spending or those facing difficulties in establishing a high historical Delaware base amount.1 This consistency in calculation, combined with the full cash refundability, ensures that Delaware’s incentive effectively transforms a localized R&D expenditure into immediate working capital. For sophisticated taxpayers, this immediacy is assessed through net present value (NPV) analysis, where the refundable credit provides a superior return compared to tax offsets or deferred carryforwards available in other jurisdictions.

II. Statutory Basis and Dual Calculation Methods (30 Del. C. § 2070)

The foundation of the Delaware R&D Tax Credit lies within Title 30, Chapter 20, Subchapter VIII of the Delaware Code.6 This legislative framework explicitly links Delaware’s definitions of “qualified research” and “qualified research expenses” (QREs) to the Internal Revenue Code (IRC) § 41, ensuring continuity and consistency with federal compliance standards.3

A. The Dual Calculation Framework for Standard Taxpayers

Delaware Code § 2070(a)(1) provides taxpayers (excluding small businesses) with an indispensable choice between two methods for determining their annual credit amount:

1. Method A (Traditional Incremental Approach): Under this method, the credit equals 10% of the amount by which the taxpayer’s Delaware QREs exceed their historical Delaware base amount.3 Calculating the Delaware base amount involves a potentially complex fixed-base percentage multiplied by the average Delaware gross receipts over the prior four years, subject to a minimum of 50% of current-year Delaware QREs.1
2. Method B (Apportioned Federal ASC – The General Rule): This elective alternative determines the credit as 50% of the portion of the federal R&D tax credit attributable to Delaware QREs, provided that the federal credit is calculated using the Alternative Simplified Credit (ASC) method under IRC § 41(c)(5).3

B. The Annual, Independent Election and Strategic Flexibility

A key administrative feature enhancing the strategic value of the Delaware credit is the independence of the state election from the federal filing position.

The taxpayer must make an annual election between Method A and Method B.3 Crucially, this state election operates entirely independent of the methodology used for the taxpayer’s federal R&D tax credit determination.3 For instance, a corporation might elect the Regular Credit for its federal Form 6765 but may still elect Method B for Delaware purposes, requiring a hypothetical calculation of the federal ASC specifically for the Delaware return.

This flexibility in choosing the calculation method is vital, as it necessitates running parallel scenarios—Method A, Method B, and potentially the actual federal calculation—to identify the optimal outcome. Because Method A requires the calculation of a historical Delaware base amount derived from up to four preceding years of Delaware QREs and gross receipts 1, Method B often presents a more reliable pathway for maximization if historical Delaware data is sparse or difficult to compile, provided the necessary federal historical QRE data for the ASC calculation is readily available.

III. Dissecting the 50% Apportionment Rate

The “50% Apportionment Rate (General Rule ASC)” is a succinct term encapsulating both the rate of subsidy applied and the underlying mechanism of geographic sourcing.

A. The Rate Multiplier (50%)

The 50% factor serves as the direct multiplier applied to the portion of the federal ASC that is successfully allocated to Delaware. For standard taxpayers (those with average annual gross receipts exceeding $20 million), this rate establishes the maximum state benefit.

The application of this 50% rate functions as a calculated state subsidy level. It ensures that the state benefit is generous yet remains capped at half of the effective federal incentive generated by the R&D activities localized within the state’s borders.1 This careful calibration supports innovation without fully duplicating the federal investment.

B. The Federal Foundation: Mandated Use of ASC (IRC § 41(c)(5))

Method B is structurally dependent on the federal Alternative Simplified Credit (ASC) defined in IRC § 41(c)(5).3 Delaware mandates the use of this federal methodology and its definitions when computing the initial credit amount, irrespective of the method used on the federal return.

The ASC method is generally preferred by businesses experiencing recent growth in R&D spending, as it provides a credit equal to 14% of the current year’s QREs that exceed 50% of the average QREs from the three prior tax years.1 This specific calculation provides a clear, mathematically defined base against which Delaware then applies its apportionment and reduction rules.

C. Compliance and the AIC/ASC Statutory Conflict

A critical nuance for tax practitioners involves a potential technical conflict between the governing Delaware statute and the procedural instruction provided by the Division of Revenue (DOR) on its forms.

The Delaware Code, in 30 Del. C. § 2070, consistently and specifically mandates the use of the Alternative Simplified Credit method under IRC § 41(c)(5) for Method B.3 However, the instructions for Delaware Form 2071AC, Part B (the application for the R&D credit), sometimes refer to the Federal Alternative Incremental Credit (AIC) under Section 41(c)(4) when referencing the federal credit input on Line 1.2

For compliance purposes, the clear language of the governing statute must take precedence over potentially outdated form instructions. The AIC is an older federal computation method, whereas the ASC (IRC $\S 41(\text{c})(5)$) is the explicit, repeated statutory requirement. Taxpayers are therefore advised to calculate their Delaware R&D credit based on the ASC methodology as dictated by 30 Del. C. § 2070, while thoroughly documenting this interpretation to address the form’s reference to the AIC.

IV. The Delaware Apportionment Mechanism: Qualified Research Expense (QRE) Ratio

Once the underlying federal ASC amount is calculated, the next critical step is to determine the precise portion of that credit that is attributable to Delaware. This process employs a specialized, highly targeted single-factor apportionment method based solely on QREs.

A. The QRE Ratio Formula

Delaware avoids the traditional, complex multi-factor formulas used for apportioning general corporate income (which typically include property, payroll, and sales factors 8). For the R&D credit, apportionment is simplified to a single ratio that measures local research expenditures against total research expenditures.3

The mechanism for determining Delaware’s share is calculated as follows:

$$\text{Apportionment Factor} = \frac{\text{Taxpayer’s Delaware Qualified Research and Development Expenses (DE QREs)}}{\text{Taxpayer’s Total Qualified Research and Development Expenses (Total QREs)}}$$

The final apportioned share is then determined by applying this factor to the derived federal ASC amount:

$$\text{Delaware’s Apportioned Share} = \text{Federal ASC Amount} \times \text{Apportionment Factor}$$

B. Defining and Sourcing Delaware Qualified Research Expenses

For multi-state businesses, the accurate sourcing of QREs is the linchpin of the Method B calculation. Delaware QREs must represent expenditures for research activities physically performed within the state.

The Delaware Code grants the Director of the Division of Revenue authority to prescribe standards for determining which QREs qualify as Delaware QREs, primarily considering the location where the services are performed.3 This requires detailed analysis of payroll records (where the research staff physically performed their work), consumption records for research supplies, and the physical location where contract research was executed.

C. Policy Purpose of the QRE Apportionment Factor

The selection of the QRE ratio as the sole apportionment factor for the R&D credit reflects a specific policy objective. The structure ensures that the state subsidy directly rewards the physical commitment of resources—labor and capital—to R&D activities within Delaware.3

This mechanism differs fundamentally from traditional state income tax apportionment models. If Delaware were to use a sales-based factor, a company with minimal R&D conducted locally but substantial sales sourced to the state might claim a credit disproportionately large relative to its Delaware research footprint. By using the QRE ratio, the state accurately targets the incentive, guaranteeing that the refundable credit directly corresponds to the degree of research activity actually performed in Delaware.

V. Delaware Division of Revenue Guidance and Compliance Mechanics

Claiming the Delaware R&D tax credit via Method B requires strict adherence to administrative procedures and deadlines established by the Delaware Division of Revenue (DOR), primarily articulated through the requirements for Form 2071AC.

A. Mandatory Filing Procedures and Deadlines

The procedural requirements emphasize mandatory pre-approval, stringent deadlines, and specific documentation:

1. Prior Approval Requirement: Any taxpayer electing to qualify for the Delaware Research & Development Tax Credits must first secure approval from the Delaware Division of Revenue.2
2. Application Deadline: The crucial administrative constraint is the application deadline. Form 2071AC, the Application for Research and Development Tax Credit, must be completed and submitted on or before September 15th after the end of the taxable year during which the qualified research and development expenses were made.2 This early deadline—often preceding the extended due date for the corporate income tax return—demands proactive compliance planning, as failure to meet the September 15th cutoff results in forfeiture of the credit for that tax year.
3. Required Attachments: Compliance necessitates attaching supporting federal documentation. A copy of Federal Form 6765 (Credit for Increasing Research Activities) must accompany the Delaware application. If the applicant is part of a consolidated group, a pro forma Federal Form 6765 for the specific corporate applicant must be attached.2
4. Final Credit Application: After receiving DOR approval, the credit amount calculated on Form 2071AC is transferred to the appropriate line on Delaware Form 700, the Delaware Income Tax Credit Schedule. Both Forms 700 and 2071AC must be attached to the annual income tax return.2

B. Step-by-Step Calculation Using Form 2071AC, Method B

The calculation procedure for Method B is clearly delineated in the Form 2071AC instructions, providing a specific roadmap for applying the federal ASC, the QRE apportionment ratio, and the final 50% multiplier.

Table 1: Step-by-Step Calculation for Method B (50% Apportioned Federal ASC)

C. Refundability and Application by Entity Type

Since January 1, 2017, the Delaware R&D Tax Credit has been fully refundable, eliminating the previous $5,000,000 cap on total credits issued.2

The fully refundable status means that if the calculated credit on Line 6 exceeds the taxpayer’s Delaware Corporate Income Tax liability, the remaining balance is paid out as a cash refund.1 This provides direct, immediate cash flow relief.

For flow-through entities, the application of the credit is adjusted:

• C Corporations: The final credit is entered on Form 700, Line 10(a).2
• S Corporations and Partnerships: The credit is calculated at the entity level but must be multiplied by the percentage of stock ownership (S-Corp) or percentage ownership (Partnership) for pass-through to the individual shareholders or partners, who then claim the credit on their personal Delaware returns (Form 700, Lines 10(b) and 10(c), respectively).2

VI. The 100% Small Business Exception: An Important Caveat

The 50% Apportionment Rate applies exclusively to the General Rule. Taxpayers must first confirm their classification, as qualifying as a “small business” fundamentally changes the calculation multiplier under Method B.

A. Defining the Small Business Threshold

Delaware defines a “small business” for R&D tax credit purposes as any taxpayer with average annual gross receipts that do not exceed the applicable threshold of $20,000,000.3 This average is determined using the federal rules set forth in IRC § 41(c)(1)(B).

B. Strategic Implications of the 100% Rate

When a taxpayer meets the small business definition, the statute adjusts the multiplier for Method B from 50% to 100% of Delaware’s apportioned share of the federal ASC.1

This provision is a deliberate policy tool designed to maximize the incentive for startups and growing enterprises. By granting the small business 100% of the apportioned federal ASC, Delaware effectively matches the federal benefit on a dollar-for-dollar basis for every qualified research expenditure located within the state. When combined with the full refundability of the credit, this 100% rate acts as a strong economic magnet, lowering the barrier to entry and investment for research-intensive small businesses, such as those in the biotechnology and high-technology sectors.1

VII. Case Study: Multi-State Taxpayer Electing Method B (50% Rule)

To illustrate the financial impact and mechanics of the 50% Apportionment Rate, consider the case of MultiCorp Innovation, a multi-state technology firm that is not a small business.

A. MultiCorp Innovation Scenario Setup

MultiCorp Innovation operates R&D facilities across three states, including Delaware. For the current tax year, the company determines that the ASC derivative (Method B) provides the optimal state credit.

B. Detailed Calculation of Delaware R&D Credit (Method B)

MultiCorp Innovation follows the required steps for Form 2071AC, Part B:

Table 2: Calculation of Delaware R&D Credit via Method B (50% Rule)

C. Financial Outcome and Method Comparison

The final Delaware R&D Credit is $162,500. Since MultiCorp’s tax liability is only $40,000, the liability is offset entirely, and the company receives a cash refund of $122,500 ($162,500 – $40,000).

For comparative purposes, assume MultiCorp had calculated a historical Delaware base amount (for Method A) of $2,000,000.

• Method A Credit: ($\$2,500,000 – \$2,000,000$) $\times 10\% = \$50,000$

In this scenario, the annual election to use Method B yielded a credit of $162,500, over three times the $50,000 available through Method A, demonstrating the critical need for robust comparative analysis prior to filing.

VIII. Strategic Considerations and Conclusion

A. Optimization: When Method B is Preferable

For standard, multi-state taxpayers, the election of Method B is fundamentally a decision based on maximizing the incremental benefit, often succeeding where Method A falls short due to historical factors:

1. Overcoming a High Base Amount: Method B utilizes the federal ASC base, which is 50% of the average QREs over the preceding three years. If a taxpayer’s historical R&D activity in Delaware was high in the base period used for Method A, the resulting high Delaware base amount could negate or minimize the Method A credit.1 Method B circumvents this high base, often generating a positive credit where Method A fails.
2. Rewarding Recent Growth: The ASC methodology is explicitly designed to reward recent, incremental increases in R&D spending, as its calculation only looks back three years and uses a fixed percentage (14%) rather than complex historical rates. This structure makes Method B highly beneficial for companies with accelerated R&D investment profiles.1
3. Mitigating Data Scarcity: Calculating the Method A base amount requires extensive historical data on Delaware QREs and Delaware gross receipts, which may be challenging to document accurately for older periods. Method B offers a cleaner alternative, provided the necessary federal QRE data for the three preceding years is available.

B. Compliance Pitfalls and Best Practices

Successful utilization of the 50% Apportionment Rate hinges on technical precision and procedural rigor:

1. Strict Adherence to Deadline: The September 15th application deadline for Form 2071AC is mandatory and non-negotiable. Tax teams must integrate this date as a high-priority cutoff point, regardless of the corporation’s overall filing extensions.2
2. Rigorous QRE Sourcing: Since the credit hinges entirely on the QRE Apportionment Factor (Line 4), exhaustive documentation proving the physical location of research activities—payroll, supplies consumption, and contractor performance—in Delaware is necessary to withstand DOR scrutiny.3
3. Statutory Consistency: Despite the contradictory language on Form 2071AC referencing the AIC, the calculation must strictly adhere to the statutory mandate of using the Alternative Simplified Credit (ASC) method under IRC § 41(c)(5) for deriving the base federal credit amount.

C. Conclusion

The 50% Apportionment Rate (General Rule ASC) is an expertly engineered component of the Delaware R&D tax incentive structure. It provides a mechanism for multi-state standard taxpayers to efficiently calculate a substantial, highly valuable refundable credit. By adopting the federal ASC methodology and utilizing a QRE-based apportionment ratio, the state ensures that the benefit is proportional to the actual economic research activity performed within its borders. The decisive factor distinguishing the Delaware credit is its full refundability, which transforms the credit from a mere tax offset into a source of immediate, non-taxable cash flow. Strategic planning requires an annual comparison of Method A versus Method B, with careful attention to the specialized QRE sourcing rules and the absolute compliance deadline of September 15th to capture the maximum available cash benefit.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/